Develops and markets platforms, tools and products that accelerate post-genomic research, the advanced study of proteins and protein pathways, and drug target discovery.
Compugen
Compugen
2024-06-14
Compugen, a genomics-based drug and diagnostic discovery company, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science, and physics into the disciplines of biology, organic chemistry, and medicine.